Clinical Trials Directory

Trials / Unknown

UnknownNCT05015062

Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, China

Effectiveness of a Mobile-based HIV Prevention Intervention for Rural and Low-income Population Involving Incentive Policy for Doctors in Liangshan, China: a Randomized Controlled Trial Protocol

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
4,000 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will be carried out in Liangshan Yi Autonomous Prefecture, Sichuan province, China, using a single-blinded randomized controlled trial design to measure the effects of a mobile-based HIV-related information intervention on group HIV/AIDS prevention. Village doctors will be responsible for sending the HIV-related health education information to the participants. The aim of this study is to develop a generalizable, effective, acceptable, and convenient mobile-based information intervention model to improve HIV-related knowledge, attitudes, practices, and health outcomes in poverty-stricken areas in China and measure the impact of incentive policies on the work of village doctors in Liangshan, China.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMobile-based HIV-related educational message deliveryHIV/AIDS awareness-raising and behavior-related cyclic messages will be delivered by the village doctors on a biweekly basis for 18 months.
BEHAVIORALIncentive policies evaluationvillage doctors in Intervention A and B will receive different types of monetary compensation. Doctors in Intervention A will receive standardized compensation for completing their assigned tasks. Doctors in Intervention B will receive performance-based compensation whose amount depends on how well the participants perform on the follow-up questionnaires.

Timeline

Start date
2023-01-01
Primary completion
2024-12-01
Completion
2025-12-01
First posted
2021-08-20
Last updated
2022-06-09

Source: ClinicalTrials.gov record NCT05015062. Inclusion in this directory is not an endorsement.